CEA is currently the most common predictor of the risk of distant metastases in CRC [22, 23], which was also demonstrated in our ROC analysis, and CEA was superior to other serum markers for the diagnosis of liver metastases in CC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.